.Nature Medication, Posted online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Point of view calls for inclusion of patients along with MASLD as well as dimension of liver outcomes in cardio-- kidney-- metabolic tests, when data suggest mechanistically conceivable benefits and also scientific safety and security-- and also describes considerations for trial style and also regulative commendation.